Literature DB >> 20805209

More evidence cannabis can help in neuropathic pain.

Henry J McQuay.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20805209      PMCID： PMC2950178          DOI： 10.1503/cmaj.100799

Source DB:  PubMed          Journal:  CMAJ        ISSN： 0820-3946            Impact factor:   8.262


× No keyword cloud information.
  8 in total

Review 1.  Are cannabinoids an effective and safe treatment option in the management of pain? A qualitative systematic review.

Authors:  F A Campbell; M R Tramèr; D Carroll; D J Reynolds; R A Moore; H J McQuay
Journal:  BMJ       Date:  2001-07-07

2.  A randomized, placebo-controlled, crossover trial of cannabis cigarettes in neuropathic pain.

Authors:  Barth Wilsey; Thomas Marcotte; Alexander Tsodikov; Jeanna Millman; Heather Bentley; Ben Gouaux; Scott Fishman
Journal:  J Pain       Date:  2008-04-10       Impact factor: 5.820

Review 3.  EFNS guidelines on the pharmacological treatment of neuropathic pain: 2010 revision.

Authors:  N Attal; G Cruccu; R Baron; M Haanpää; P Hansson; T S Jensen; T Nurmikko
Journal:  Eur J Neurol       Date:  2010-04-09       Impact factor: 6.089

4.  Cannabis in painful HIV-associated sensory neuropathy: a randomized placebo-controlled trial.

Authors:  D I Abrams; C A Jay; S B Shade; H Vizoso; H Reda; S Press; M E Kelly; M C Rowbotham; K L Petersen
Journal:  Neurology       Date:  2007-02-13       Impact factor: 9.910

5.  Smoked cannabis for chronic neuropathic pain: a randomized controlled trial.

Authors:  Mark A Ware; Tongtong Wang; Stan Shapiro; Ann Robinson; Thierry Ducruet; Thao Huynh; Ann Gamsa; Gary J Bennett; Jean-Paul Collet
Journal:  CMAJ       Date:  2010-08-30       Impact factor: 8.262

6.  Does the cannabinoid dronabinol reduce central pain in multiple sclerosis? Randomised double blind placebo controlled crossover trial.

Authors:  Kristina B Svendsen; Troels S Jensen; Flemming W Bach
Journal:  BMJ       Date:  2004-07-16

7.  Smoked medicinal cannabis for neuropathic pain in HIV: a randomized, crossover clinical trial.

Authors:  Ronald J Ellis; Will Toperoff; Florin Vaida; Geoffrey van den Brande; James Gonzales; Ben Gouaux; Heather Bentley; J Hampton Atkinson
Journal:  Neuropsychopharmacology       Date:  2008-08-06       Impact factor: 7.853

8.  Comparison of analgesic effects and patient tolerability of nabilone and dihydrocodeine for chronic neuropathic pain: randomised, crossover, double blind study.

Authors:  B Frank; M G Serpell; J Hughes; J N S Matthews; D Kapur
Journal:  BMJ       Date:  2008-01-08
  8 in total
  2 in total

1.  Pharmacological modulation of neuropathic pain-related depression of behavior: effects of morphine, ketoprofen, bupropion and [INCREMENT]9-tetrahydrocannabinol on formalin-induced depression of intracranial self-stimulation in rats.

Authors:  Michael D Leitl; S Stevens Negus
Journal:  Behav Pharmacol       Date:  2016-06       Impact factor: 2.293

2.  Adherence to Medical Cannabis Among Licensed Patients in Israel.

Authors:  Yuval Zolotov; Yehuda Baruch; Haim Reuveni; Racheli Magnezi
Journal:  Cannabis Cannabinoid Res       Date:  2016-01-01
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.